Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Products affected by action to stop imports from Micro Labs in India Health Canada took action on October 27, 2014 to stop the import of health products from the following sites in India: Micro Labs - Bangalore, Goa and Tamil Nadu/Hosur. These lists are based on the most recent…
Products affected by action to stop imports from ARPL, APIPL and IPCA facilities in India Updated: July 25, 2016 Health Canada took action on September 30, 2014 to stop the import of health products from the following sites in India: Apotex Pharmachem India Pvt Ltd (APIPL) Apotex…
Zhejiang Hisun Pharma Company Ltd. Health Canada has requested Canadian importers and distributors to voluntarily quarantine drugs imported from Zhejiang Hisun Pharma Company Ltd., in Zhejiang, China, due to data integrity concerns. This list is based on the most recent…
Hospira S.P.A Health Canada is restricting the importation of drugs from Hospira S.P.A. in Liscate, Italy , due to data integrity concerns. These lists are based on the most recent information received by Health Canada as of June 12, 2015, from various importers and companies and…
Impurities found in certain angiotensin II receptor blocker (ARB) products, also known as sartans Table of Contents Overview Recalls Test Results Test Method Health Canada Communications Overview In the summer of 2018, several valsartan products were recalled in Canada and…
Active Ingredients The extension of Good Manufacturing Practices (GMP) to Active Pharmaceutical Ingredients (APIs) has increasingly been recognized as a necessary element in ensuring the overall quality and consistency of marketed drug products. For this reason, the International…
Thinking about banking your child’s cord blood? Find information on cord blood, its use and how we regulate human cord blood banks in Canada, to help you make an informed decision about banking your child's cord blood. On this page What is cord blood Why store cord blood What is…
List of Registered Cells, Tissues and Organs (CTO) Establishments In accordance with the Safety of Human Cells, Tissues and Organs for Transplantation Regulations ( CTO Regulations), all source establishments and establishments that distribute or import for further distribution,…
Human Cells, Tissues and Organs for Transplantation - Error or Accident Investigation Reporting Form (FRM-0172) Introduction The Safety of Human Cells, Tissues and Organs (CTO) for Transplantation Regulations require that suspected errors or accidents (E/A) identified after the…
Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations: Overview Overview Implementation Classification of CTOs Testing for infectious diseases Download in PDF format (1.22 MB, 125 pages) Organization: Health Canada Date published: 2025-03-12…
Early release: coverage is bounded to the current corpus, and features may change.
